Clinical OMICS

JAN-FEB 2019

Healthcare magazine for research scientists, labs, pathologists, hospitals, cancer centers, physicians and biopharma companies providing news articles, expert interviews and videos about molecular diagnostics in precision medicine

Issue link:

Contents of this Issue


Page 2 of 51

VOL. 6, Issue No. 1 January/February 2019 January/February 2019 Clinical OMICs 1 @ClinicalOMICs 30 | FEATURE Beyond Sequencing: New Approaches to Examining DNA Are Helping to Advance Precision Medicine 36 | Breaking New Ground in Liquid Biopsy: Advancements in Detection of Cell-Free Tumor DNA in Plasma and CFS Extending LBx Reach 40 | 2018 Year In Review: Our Editors Pick Three Events from the Past Year That Could Leave Lasting Legacies 44 | Precision for All: The Case for Equity in Clinical Genomics and Research 39 | NEW PRODUCTS 48 | INDUSTRY EVENTS Genomic Medicine for the Masses Building from the success of the 100,000 Genomes Project, England's National Health Service pushes forward with a genomic medicine service for all 55 million citizens. 24 The CDx Conundrum While there is an increase in companion diagnostic approvals, LDTs and securing adequate reimbursement present commercialization challenges. 12 3 | FROM THE EDITOR Are We Ready for Precision Medicine? 8 | Pursuing Greater Precision: Adam Margolin Leads $200M Expansion of Mount Sinai's Precision Medicine Program 16 | Tools for Translation: DNAnexus CEO Richard Daly Discusses the Role Translational Informatics Plays in Precision Medicine 20 | FEATURE Eyeing Epigenetics: Researchers Make Inroads to Understand Disease Via How Genes Are Affected by Environment Cover: Mon Oo Yee; Above (top right) Mon Oo Yee; (top left) AlexLMX / iStock / Getty Images; (middle right) Karius Inc. (bottom left) Nipitpon Singad / EyeEm / Getty Images;

Articles in this issue

Links on this page

Archives of this issue

view archives of Clinical OMICS - JAN-FEB 2019